by admin_63069 | Sep 23, 2024 | Related Topics
This could be a game changer in prostate cancer diagnosis.
by admin_63069 | Sep 16, 2024 | Related Topics
Following treatment with olaparib, 13 participants, including all 11 who had BRCA2 mutations, had a decrease in PSA of at least 50% — a sign that their cancers were receding.
by admin_63069 | Sep 9, 2024 | Related Topics
In this interview, Brian T. Helfand, MD, PhD, a urologic oncologist at NorthShore University HealthSystem in Chicago, Illinois, highlights potential advances in PSMA-PET imaging.
by admin_63069 | Sep 2, 2024 | Related Topics
Learn how advances in AI use to better conduct diagnostic imaging, predict clinical outcomes, evaluate histopathology, and plan treatment.
by admin_63069 | Aug 26, 2024 | Related Topics
Inadvertent harm from the designation and label of ‘cancer’
by admin_63069 | Aug 19, 2024 | Related Topics
From radiopharmaceuticals to hypofractionated radiation therapy, one expert explained the current landscape of radiation treatments for prostate cancer.
